Enterprise League logo

Product

SA53

BIOTECHNOLOGY

byLamassu BioTech

United States (US)

ABOUT THE PRODUCT

A novel genetically targeted therapy for locally advanced metastatic p53 wild-type tumors, currently in Phase 1/2a clinical trials.

Information is owner-confirmed

Last updated 0 month ago

Price range
N/A

Other products/services from Lamassu BioTech